Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5274| Title: | Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches | Authors: | Holtmann, Gerald Schrenk, Dietmar Madisch, Ahmed Allescher, Hans D Ulrich-Merzenich, Gudrun Mearin, Fermin Larrey, Dominique Malfertheiner, Peter |
Issue Date: | 2020 | Journal: | Digestive diseases (Basel, Switzerland) | Abstract: | Herbal or complementary medicines are frequently used for the treatment of patients with functional gastrointestinal disorders (FGID). Regulatory requirements for herbal therapies are inconsistent and, in many jurisdictions, herbal therapies are either self-, minimally- or unregulated. | DOI: | 10.1159/000504570 | metadata.dc.rights.holder: | Holtmann, Gerald | Type: | Article |
| Appears in Sites: | Gastroenterology and Hepatology, Princess Alexandra Hospital |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.